학술논문
Efficacy and safety of stapokibart (CM310) in uncontrolled seasonal allergic rhinitis (MERAK): an investigator-initiated, placebo-controlled, randomised, double-blind, phase 2 trial
Document Type
Article
Author
Source
In eClinicalMedicine March 2024 69
Subject
Language
ISSN
2589-5370